April 25, 2018

(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the House Energy and Commerce Health Subcommittee’s consideration of H.R. 3528 / S. 2460 the Every Prescription Conveyed Securely Act, which requires electronic prescribing (e-prescribing) for controlled substances in Medicare Part D.

“E-prescribing helps ensure each prescription is written by a legitimate provider and filled at a legitimate pharmacy. This bill is an important solution that attacks the opioid epidemic by preventing doctor shopping and drugstore and reducing costs inflicted on patients and taxpayers.”

A new study by Health IT Now’s Opioid Safety Alliance finds H.R. 3528 would reduce federal spending $13 billion over 10 years. This is consistent with a separate study by Visante and Point-of-Care Partners that finds mandatory e-prescribing of controlled substances in Medicare would save the federal government more than $2 billion annually – due to decreased treatment costs and greater efficiencies in physician offices and pharmacies, among other factors.

A broad coalition supports passage of H.R. 3528, including:

  • Pharmaceutical Care Management Association
  • CVS Health
  • Express Scripts
  • Magellan Health
  • Prime Therapeutics
  • Albertsons Companies
  • America’s Health Insurance Plans
  • AmerisourceBergen
  • Association for Accessible Medicines
  • College of Healthcare Information Management Executives
  • Healthcare Information and Management Systems Society
  • Health IT Now
  • Imprivata
  • National Coalition on Health Care
  • National Consumers League
  • National Association of Chain Drug Stores
  • National Community Pharmacists Association
  • Rite Aid
  • Surescripts
  • Walgreens